Literature DB >> 6426756

Viral hepatitis and the anaesthetist.

R A Browne, M A Chernesky.   

Abstract

Viral hepatitis is a constant hazard to all operating room personnel. The anaesthetist should avoid contact with patients' blood and saliva as much as is possible. Hepatitis A (HAV) is spread mainly by faecal/oral contact. Carriers are almost non-existent in this disease and the main importance to the anaesthetist is that he may contact a patient who is acutely infected or one who is incubating HAV. Diagnosis of postoperative hepatic dysfunction may then be a problem. Prophylaxis with Gamma globulin is also stressed. Hepatitis B (HBV) and Non-A Non-B hepatitis (NANB) have a high incidence of carriage, and are spread mainly by blood contact. The groups of patients whom the anaesthetist should especially be aware of are reviewed, as is prophylaxis using Hepatitis B Immune Globulin and the recently introduced Hepatitis B vaccine. NANB continues to be a diagnostic problem, its diagnosis being mainly by exclusion of other causes of viral hepatitis. It appears to be responsible for more than 90 per cent of cases of posttransfusion hepatitis and more than one virus may be involved.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6426756     DOI: 10.1007/bf03007889

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  42 in total

1.  The economic impact of viral hepatitis in the United States.

Authors:  D D Tolsma; J A Bryan
Journal:  Public Health Rep       Date:  1976 Jul-Aug       Impact factor: 2.792

2.  Role of hepatitis-B antigen carriers in non-parenteral transmission of the hepatitis-B virus.

Authors:  J Heathcote; P Gateau; S Sherlock
Journal:  Lancet       Date:  1974-08-17       Impact factor: 79.321

3.  Some observations on the ecology of infectious hepatitis.

Authors:  H O Lobel; R W McCollum
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408

4.  Incubation period of type B hepatitis.

Authors:  S Krugman
Journal:  N Engl J Med       Date:  1979-03-15       Impact factor: 91.245

5.  The liver and anaesthesia.

Authors:  L Strunin; J M Davies
Journal:  Can Anaesth Soc J       Date:  1983-03

6.  Prevalence of serum-hepatitis-related antigen (SH) in different geographic regions.

Authors:  A M Prince
Journal:  Am J Trop Med Hyg       Date:  1970-09       Impact factor: 2.345

7.  Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen.

Authors:  J H Hoofnagle; L B Seeff; Z B Bales; H J Zimmerman
Journal:  N Engl J Med       Date:  1978-06-22       Impact factor: 91.245

8.  Hepatitis B virus antibody prevalence in anaesthetists.

Authors:  M A Chernesky; R A Browne; P Rondi
Journal:  Can Anaesth Soc J       Date:  1984-05

9.  Hepatitis B vaccine administered to chronic carriers of hepatitis b surface antigen.

Authors:  J L Dienstag; C E Stevens; A K Bhan; W Szmuness
Journal:  Ann Intern Med       Date:  1982-05       Impact factor: 25.391

10.  Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis virus aetiology.

Authors:  D C Wong; R H Purcell; M A Sreenivasan; S R Prasad; K M Pavri
Journal:  Lancet       Date:  1980-10-25       Impact factor: 79.321

View more
  1 in total

1.  Acute hepatitis after isoflurane anesthesia.

Authors:  J A Webster
Journal:  CMAJ       Date:  1986-12-15       Impact factor: 8.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.